Medical device registration in international markets involves more than obtaining approval in a manufacturer’s home country. Regulatory requirements vary by country and region, including device classification, technical documentation, clinical evidence, labeling, language, and post-market obligations. A device that meets the requirements of one market may need additional evidence or documentation before it can be placed on another market.
For manufacturers planning international expansion, early regulatory planning is essential. Translation and localization should also be considered from the beginning, particularly when technical files, clinical documents, labels, and instructions for use must be prepared in multiple languages.
Medical Device Registration Requirements Across Global Markets
There is no single global registration process for medical devices. Requirements depend on the target market, device classification, intended use, risk level, and regulatory pathway.
Most regulatory systems require manufacturers to demonstrate that a device meets applicable safety and performance requirements. However, the way manufacturers provide this evidence can differ considerably.
European Union
Medical devices in the European Union are primarily regulated under Regulation (EU) 2017/745, commonly known as the Medical Devices Regulation (MDR). Manufacturers must demonstrate conformity with applicable requirements, prepare technical documentation, and follow the appropriate conformity assessment procedure. Depending on the device classification, this may involve assessment by a Notified Body before CE marking can be applied.
The MDR emphasizes clinical evaluation, risk management, post-market surveillance, and documentation throughout the device lifecycle. The EU’s EUDAMED system also supports the registration and oversight of medical devices and economic operators, making both initial conformity and ongoing regulatory obligations important considerations.
United States
In the United States, the Food and Drug Administration (FDA) regulates medical devices through different pathways based largely on classification and risk.
Some devices may be exempt from premarket submission, while others may require a 510(k) premarket notification, De Novo classification request, or Premarket Approval (PMA). A 510(k) generally requires manufacturers to demonstrate substantial equivalence to a legally marketed predicate device. At the same time, PMA applies to certain high-risk devices and requires scientific evidence supporting safety and effectiveness.
Authorization obtained in another country does not automatically satisfy FDA requirements. Manufacturers must prepare submissions according to the applicable US pathway.
United Kingdom
Great Britain has its own regulatory framework for medical devices. The Medicines and Healthcare products Regulatory Agency (MHRA) regulates devices placed on the Great Britain market, and manufacturers generally must register with the MHRA.
Manufacturers outside the UK generally need a UK Responsible Person to act on their behalf. Northern Ireland has different requirements because EU medical device regulations continue to apply there in relevant circumstances.
Asia-Pacific Markets
Regulatory systems also differ across Asia-Pacific markets. Australia, for example, requires most medical devices to be included in the Australian Register of Therapeutic Goods (ARTG), with requirements determined partly by device classification.
China operates a three-class system, with different registration or filing requirements depending on the device. Imported Class II and Class III devices must be registered with China’s National Medical Products Administration (NMPA), and Chinese-language documentation is an important part of the process.
Japan also has its own regulatory framework, involving authorities such as the Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency. These differences mean manufacturers need a market-specific registration strategy rather than simply reusing the same submission package everywhere.
What Does the Registration Process Involve?
Although procedures vary, international medical device registration commonly involves several key stages.
1. Determine device classification
Manufacturers first need to establish whether the product is regulated as a medical device in the target market and determine its classification. Classification can affect the regulatory pathway, evidence requirements, conformity assessment, and level of regulatory review.
2. Prepare technical documentation
Technical documentation provides evidence that the device meets applicable requirements. Depending on the market and product, documentation may include:
- Device description and specifications
- Design and manufacturing information
- Risk management documentation
- Verification and validation results
- Quality management system information
- Software documentation, where applicable
- Biocompatibility and safety data
- Clinical evaluation or investigation data
- Post-market surveillance documentation
The same core information may apply across markets, but you may need to adapt its structure, content, or supporting evidence to local requirements.
3. Establish clinical evidence
Clinical evidence helps demonstrate that a device performs as intended and is sufficiently safe for its intended use. Requirements vary according to factors such as risk, intended purpose, technology, and regulatory pathway.
Manufacturers should assess clinical evidence requirements early. Identifying gaps after preparing a submission can lead to additional testing, documentation work, and delays.
4. Adapt labeling and instructions
Labels, packaging, instructions for use, warnings, contraindications, symbols, and other product information may be regulated. Localization involves more than translating words. Content may need to reflect local terminology, measurement units, regulatory statements, responsible-party information, and other market-specific requirements.
For companies entering several markets, this can create a substantial multilingual documentation workload.
Best Practices for Global Medical Device Registration
- Understand market-specific requirements early: Research each target market before finalizing the global launch plan. Identify its device classification, regulatory pathway, clinical evidence requirements, labeling and language requirements, and post-market obligations. Early planning helps identify regulatory differences before they affect submission timelines.
- Prepare and manage documentation carefully: Global registration can involve numerous documents and versions. Establish clear processes for document ownership, version control, terminology, and review. Changes to device specifications or safety information should be tracked across technical files, clinical documents, labels, packaging, and instructions for use.
- Build translation and localization into the timeline: Translation should begin as part of regulatory planning, not after the submission package is complete. Documents may need to meet specific language and formatting requirements, while safety-critical content requires particular attention to accuracy. Specialized medical translators can help preserve technical meaning while adapting content to local regulatory and linguistic requirements.
- Maintain consistent terminology across markets: Use a controlled multilingual glossary to keep device names, components, indications, warnings, and technical terms consistent across submissions. At the same time, allow necessary local adaptations where regulatory requirements or established terminology differ.
Conclusion
Medical device registration in global markets requires manufacturers to understand and respond to the requirements of each target market. Classification, technical documentation, clinical evidence, labeling, language, and post-market requirements can all vary between jurisdictions.
Translation and localization are therefore important parts of regulatory preparation. Accurate multilingual documentation helps manufacturers communicate safety, performance, and product information consistently while meeting local requirements.
EC Innovations provides medical device translation services to support manufacturers with multilingual technical, clinical, regulatory, and labeling content for international markets. Contact us to discuss your medical device translation and localization requirements.
